These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 14623176

  • 1. Plasma nitric oxide level in familial Mediterranean fever and its modulations by Immuno-Guard.
    Panossian A, Hambartsumyan M, Panosyan L, Abrahamyan H, Mamikonyan G, Gabrielyan E, Amaryan G, Astvatsatryan V, Wikman G.
    Nitric Oxide; 2003 Sep; 9(2):103-10. PubMed ID: 14623176
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T, Sato S, Miyamoto J, Hagimori N, Kawazoe Y, Arinaga K, Fukushima C, Yamamoto H, Kawakami A.
    Trials; 2018 Dec 29; 19(1):715. PubMed ID: 30594222
    [Abstract] [Full Text] [Related]

  • 3. Adrenomedullin and total nitrite levels in children with familial Mediterranean fever.
    Balat A, Işlek I, Cekmen M, Yürekli M, Tekin D, Muslu A, Sahinöz S.
    J Paediatr Child Health; 2006 May 29; 42(5):240-3. PubMed ID: 16712551
    [Abstract] [Full Text] [Related]

  • 4. Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?
    Omma A, Sandikci SC, Kücüksahin O, Alisik M, Erel O.
    J Korean Med Sci; 2017 Oct 29; 32(10):1588-1594. PubMed ID: 28875601
    [Abstract] [Full Text] [Related]

  • 5. Is Familial Mediterranean Fever a thrombotic disease or not?
    Demirel A, Celkan T, Kasapcopur O, Bilgen H, Ozkan A, Apak H, Arisoy N, Yildiz I.
    Eur J Pediatr; 2008 Mar 29; 167(3):279-85. PubMed ID: 17436016
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of hearing in pediatric familial Mediterranean fever patients during attack period and attack-free period.
    Salimov A, Akyol U, Cildir B, Batu ED, Ozen S.
    Int J Pediatr Otorhinolaryngol; 2019 Apr 29; 119():185-192. PubMed ID: 30743166
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic validity of colchicine in patients with Familial Mediterranean fever.
    Ozaltin F, Bilginer Y, Gülhan B, Bajin I, Erdogan O, Hayran M, Yılmaz E, Ozen S.
    Clin Rheumatol; 2014 Jul 29; 33(7):969-74. PubMed ID: 24740462
    [Abstract] [Full Text] [Related]

  • 8. Update on the management of colchicine resistant Familial Mediterranean Fever (FMF).
    El Hasbani G, Jawad A, Uthman I.
    Orphanet J Rare Dis; 2019 Oct 15; 14(1):224. PubMed ID: 31615541
    [Abstract] [Full Text] [Related]

  • 9. Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever.
    Erken E, Ozer HT, Gunesacar R.
    Rheumatol Int; 2006 Jul 15; 26(9):862-4. PubMed ID: 16397779
    [Abstract] [Full Text] [Related]

  • 10. Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial.
    Hashkes PJ, Spalding SJ, Giannini EH, Huang B, Johnson A, Park G, Barron KS, Weisman MH, Pashinian N, Reiff AO, Samuels J, Wright DA, Kastner DL, Lovell DJ.
    Ann Intern Med; 2012 Oct 16; 157(8):533-41. PubMed ID: 23070486
    [Abstract] [Full Text] [Related]

  • 11. Interferon-gamma levels in familial Mediterranean fever.
    Köklü S, Oztürk MA, Balci M, Yüksel O, Ertenli I, Kiraz S.
    Joint Bone Spine; 2005 Jan 16; 72(1):38-40. PubMed ID: 15681246
    [Abstract] [Full Text] [Related]

  • 12. Plasma and platelet serotonin levels in familial Mediterranean fever.
    Onat AM, Ozçakar L, Oztürk MA, Uçar G, Ureten K, Dagli N, Kiraz S, Ertenli I, Calgüneri M.
    Clin Exp Rheumatol; 2007 Jan 16; 25(4 Suppl 45):S16-20. PubMed ID: 17949546
    [Abstract] [Full Text] [Related]

  • 13. Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever.
    Ozel AM, Demirturk L, Aydogdu A, Gultepe M, Yazgan Y, Imirzalioglu N, Gurbuz AK, Narin Y.
    Int J Clin Pract; 2008 May 16; 62(5):754-61. PubMed ID: 17343670
    [Abstract] [Full Text] [Related]

  • 14. Is there a relationship between serum omentin level and acute phase response in patients with familial Mediterranean fever?
    Can Sandikci S, Omma A, Yucel C, Omma T.
    Clin Rheumatol; 2021 Feb 16; 40(2):669-674. PubMed ID: 32623649
    [Abstract] [Full Text] [Related]

  • 15. Interventions for reducing inflammation in familial Mediterranean fever.
    Wu B, Xu T, Li Y, Yin X.
    Cochrane Database Syst Rev; 2015 Mar 20; (3):CD010893. PubMed ID: 25791871
    [Abstract] [Full Text] [Related]

  • 16. Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ben-Zvi I, Kukuy O, Giat E, Pras E, Feld O, Kivity S, Perski O, Bornstein G, Grossman C, Harari G, Lidar M, Livneh A.
    Arthritis Rheumatol; 2017 Apr 20; 69(4):854-862. PubMed ID: 27860460
    [Abstract] [Full Text] [Related]

  • 17. Plasma levels of soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) in familial Mediterranean fever.
    Başar O, Oztürk MA, Köklü S, Ayaz S, Yüksel O, Kiraz S, Ertenli I, Calgüneri M.
    Joint Bone Spine; 2007 Jan 20; 74(1):52-5. PubMed ID: 17223601
    [Abstract] [Full Text] [Related]

  • 18. Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever.
    Notarnicola C, Didelot MN, Seguret F, Demaille J, Touitou I.
    Genes Immun; 2002 Feb 20; 3(1):43-5. PubMed ID: 11857061
    [Abstract] [Full Text] [Related]

  • 19. Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever.
    Kiraz S, Ertenli I, Arici M, Calgüneri M, Haznedaroglu I, Celik I, Pay S, Kirazli S.
    Clin Exp Rheumatol; 1998 Feb 20; 16(6):721-4. PubMed ID: 9844766
    [Abstract] [Full Text] [Related]

  • 20. Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF?
    Terekeci HM, Oktenli C, Ozgurtas T, Nalbant S, Top C, Celik S, Tapan S, Kucukardali Y, Sanisoglu YS, Solmazgul E, Sahan B, Sayan O.
    J Rheumatol; 2008 Oct 20; 35(10):2024-9. PubMed ID: 18785307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.